Nipro (FRA:5FA) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5FA Nipro Corp FRA:5FA
71 GF Score
Price €7.85
GF Value €7.93
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Nipro Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nipro  (FRA:5FA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Nipro Cyclically Adjusted PB Ratio Related Terms


Nipro Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Nipro's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro Cyclically Adjusted PB Ratio Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.78 0.77 0.83 0.81

Nipro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.85 0.78 0.82 0.81

FRA:5FA vs ISRG, BDX, RMD: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Nipro's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Cyclically Adjusted PB Ratio falls into.


FRA:5FA
71GF Score
Nipro Corp FRA:5FA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Nipro's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Nipro's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=11.135/113.6000*113.6000
=11.135

Current CPI (Jun. 2026) = 113.6000.

Nipro Quarterly Data

Book Value per Share CPI Adj_Book
201609 7.941 98.000 9.205
201612 8.018 98.400 9.257
201703 8.908 98.100 10.315
201706 8.599 98.500 9.917
201709 8.601 98.800 9.889
201712 8.661 99.400 9.898
201803 8.429 99.200 9.653
201806 8.303 99.200 9.508
201809 8.408 99.900 9.561
201812 8.376 99.700 9.544
201903 8.477 99.700 9.659
201906 8.553 99.800 9.736
201909 8.674 100.100 9.844
201912 8.654 100.500 9.782
202003 8.346 100.300 9.453
202006 7.964 99.900 9.056
202009 8.036 99.900 9.138
202012 8.045 99.300 9.204
202103 8.217 99.900 9.344
202106 8.661 99.500 9.888
202109 9.045 100.100 10.265
202112 9.071 100.100 10.294
202203 9.074 101.100 10.196
202206 9.379 101.800 10.466
202209 10.255 103.100 11.299
202212 10.457 104.100 11.411
202303 10.269 104.400 11.174
202306 9.689 105.200 10.463
202309 10.632 106.200 11.373
202312 11.049 106.800 11.752
202403 10.120 107.200 10.724
202406 10.116 108.200 10.621
202409 11.451 108.900 11.945
202412 10.220 110.700 10.488
202503 11.828 111.100 12.094
202506 10.742 111.700 10.925
202509 10.520 112.000 10.670
202512 10.484 113.000 10.540
202603 11.198 112.700 11.287
202606 11.135 113.600 11.135

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Nipro (FRA:5FA) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be undervalued. The current stock price of €7.85 is trading 1% below its estimated GF Value™ of €7.93. GuruFocus considers Nipro to be Fairly Valued.

Key valuation signals for FRA:5FA:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €7.93 vs. price of €7.85 (1% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the FRA:5FA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nipro Business Description

Other Exchanges 8086:Japan
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
71GF Score

Get the complete analysis for FRA:5FA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.85
Price
€7.93
GF Value